Annovis Bio (ANVS) Director Buys 34,000 Shares—Is This the Biggest Insider Bullish Signal of 2025?
Annovis Bio, Inc. (NASDAQ:ANVS) is a clinical-stage biotechnology company founded with a singular mission: to develop transformative therapies…
Browsing Tag